Success Metrics

Clinical Success Rate

86.3%

Based on 69 completed trials

Completion Rate

86%(69/80)

Active Trials

3(3%)

Results Posted

45%(31 trials)

Terminated

11(11%)

Phase Distribution

Ph phase_1

15%

Ph phase_4

21%

Ph early_phase_1

Ph phase_2

27%

Ph not_applicable

14%

Ph phase_3

13%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution95 total trials

Early Phase 1First-in-human

4(4.2%)

Phase 1Safety & dosage

15(15.8%)

Phase 2Efficacy & side effects

28(29.5%)

Phase 3Large-scale testing

13(13.7%)

Phase 4Post-market surveillance

21(22.1%)

N/ANon-phased studies

14(14.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

79.3%

69 of 87 finished

Non-Completion Rate

20.7%

18 ended early

Currently Active

trials recruiting

Total Trials

102

all time

Status Distribution

Active(5)

Completed(69)

Terminated(18)

Other(10)

Detailed Status

Completed69

Terminated11

unknown9

Withdrawn7

Recruiting3

Not yet recruiting2

Development Timeline

Analytics

Development Status

Total Trials

102

Active

Success Rate

86.3%

Most Advanced

Phase 4

Trials by Phase

Early Phase 14 (4.2%)

Phase 115 (15.8%)

Phase 228 (29.5%)

Phase 313 (13.7%)

Phase 421 (22.1%)

N/A14 (14.7%)

Trials by Status

suspended11%

terminated1111%

not_yet_recruiting22%

recruiting33%

unknown99%

withdrawn77%

completed6968%

Recent Activity

3 active trials

Showing 5 of 102

completedphase_4

Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening

NCT04675788

recruitingphase_2

COMPASS - COpenhagen MenoPAuSe Study

NCT07254429

not_yet_recruitingnot_applicable

The Role of Estrogen and Testosterone in Determining Brain Blood Flow and Metabolic Regulation in Humans

NCT07212712

completedearly_phase_1

Hormonal Mechanisms of Sleep Restriction

NCT02256865

not_yet_recruitingphase_2

A Dose Ranging Study to Examine TDS-Testosterone 5%

NCT01894308

View all 102 trials

Clinical Trials (102)

Showing 20 of 102 trialsScroll for more

NCT04675788Phase 4

Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening

Completed

NCT07254429Phase 2

COMPASS - COpenhagen MenoPAuSe Study

Recruiting

NCT07212712Not Applicable

The Role of Estrogen and Testosterone in Determining Brain Blood Flow and Metabolic Regulation in Humans

Not Yet Recruiting

NCT02256865Early Phase 1

Hormonal Mechanisms of Sleep Restriction

Completed

NCT01894308Phase 2

A Dose Ranging Study to Examine TDS-Testosterone 5%

Not Yet Recruiting

NCT06670053

Puberty, Testosterone, and Brain Development

Recruiting

NCT02938923Phase 3

Starting a Testosterone and Exercise Program After Hip Injury

Completed

NCT01573442Phase 3

Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment

Completed

NCT02990533Phase 1

Muscle Anabolic Interventions to Accelerate Recovery From Hospitalization in Geriatric Patients

Completed

NCT05781685Early Phase 1

The Influence of Testosterone on Experimental Pain Perception

Completed

NCT02873559Phase 2

Effect of PROGRESSive Training and Teststerone in Older Frail Men

Completed

NCT06149065

Factors Associated With the Acne Severity Among Transmen Population: a Cross-sectional Study

Completed

NCT01460654Phase 2

Testosterone and Alendronate in Hypogonadal Men

Terminated

NCT05773183

Exploring the Relationship Between Androgen Metabolism, Metabolic Disease and Skeletal Muscle Energy Balance in Men

Unknown

NCT01127659Phase 4

Testosterone Replacement in Men With Diabetes and Obesity

Completed

NCT02367105Phase 3

Lifestyle Intervention and Testosterone Replacement in Obese Seniors

Completed

NCT00504712Phase 4

Testosterone for Peripheral Vascular Disease

Completed

NCT05367284

Perioperative Testosterone Replacement Therapy in Sarcopenic Male Colorectal Cancer Patients

Unknown

NCT01595581Phase 3

Testosterone Administration and ACL Reconstruction in Men

Completed

NCT00009555Phase 4

Testosterone for HIV-Positive Men With Reduced Serum Testosterone Levels and Abdominal Fat

Completed

Drug Details

Intervention Type: DRUG
Total Trials: 102